Patients Coming Off Anti-Obesity Medications Regain Weight Four Times Faster Than People Using Diet and Exercise
Fresh analysis reveals that patients who stop using blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who end traditional lifestyle plans.
Published data in a prominent medical journal points out that while overweight individuals often shed about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals buying such drugs must be informed of the danger of rapid weight regain when the medication is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery means a reversion to starting mass in about a year and a half.
Weighing Therapies
The study, which examined dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with other pills.
The team note that individuals who shed pounds through dieting typically see a more gradual creep back—perhaps 100 grams monthly—once they finish.
Understanding the Fast Rebound
Nutrition scientists believe the mode of action of the injections explains the accelerated regain.
These medications copy a natural hormone called GLP-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations far above than normal might result in the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement results in appetite is no longer kept in check, making overeating much more probable."
A Chronic Issue?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts argue that, given the high risk of weight regain, the treatment might need to be life-long.
This view is reinforced by pharmaceutical companies, who note that the findings "highlight the persistent nature of excess weight," similar to managing conditions like high blood pressure.
User Accounts
People who have come off the jabs describe a intense resurgence of appetite.
"It was like something activating and you become starving," recalled a patient.
This challenge is compounded if patients have not established permanent lifestyle or habit changes during treatment.
Growing Interest
Figures show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is more common among women than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
Finally, clinicians stress that while these medications are potent tools for weight loss, they are not a permanent fix and lasting health benefits likely depends on integrated lifestyle management.